COMMUNIQUÉS West-GlobeNewswire

SYNC Supplement Claims Evaluated: The Revive Daily Sunlight Loophole Formula for Healthy Circadian-Rhythm Support
04/05/2026
How the Sunlight Loophole Circadian Rhythm Supplement Works: Clock Gene Support, Morning Metabolism Alignment, and DSHEA Ingredient Standards Explained Aurora, CO, May 04, 2026 (GLOBE NEWSWIRE) -- These statements have [...]
Eascra Biotech Welcomes Dr. Anne Yau as Life Science Research Scientist
04/05/2026
Nanomedicine expert joins Massachusetts Biomedical Initiatives (MBI) lab in Worcester to advance RNA therapeutics for musculoskeletal disease WORCESTER, Mass., May 04, 2026 (GLOBE NEWSWIRE) -- Eascra Biotech , a [...]
EssilorLuxottica: Disclosure of transactions in own shares
04/05/2026
Disclosure of transactions in own shares Paris, France (May 4, 2026 - 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders’ Meeting held on April 30, 2025, and, with respect to transactions [...]
EssilorLuxottica: Déclaration de transactions sur actions propres
04/05/2026
Déclaration de transactions sur actions propres Paris, France (4 mai 2026, 18h00) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 30 avril 2025, et, pour les opérations réalisées postérieurement à l [...]
Confluent Medical Technologies Announces Nitinol Wire Center of Excellence
04/05/2026
Confluent Unveils New Nitinol Wire Manufacturing Facility in Hyderabad, India SCOTTSDALE, Ariz., May 04, 2026 (GLOBE NEWSWIRE) -- Confluent Medical Technologies (Confluent), a leading medical device and materials [...]
Xpress Wellness Acquires Wichita’s Mental Health Practice Midwest Counseling Services
04/05/2026
Acquisition furthers Xpress Wellness’ future growth in behavioral health in Kansas and Adjacent State Key facts of this press release: Xpress Wellness acquired Wichita’s Midwest Counseling Services on April 1, 2026 [...]
Zelluna ASA: Invitation to First Quarter 2026 results webcast Presentation (corrected time)
04/05/2026
Oslo, Norway, 4 May 2026 – Zelluna (OSE: ZLNA), a company pioneering allogeneic “off-the-shelf” T-cell receptor-based natural killer (TCR-NK) therapies for the treatment of cancer, invites to a webcast presentation of [...]
TimelyCare Acquires Alongside to Expand Continuous Student Support with Clinician-Powered AI Coaching
04/05/2026
Acquisition adds an early-intervention and engagement layer to TimelyCare’s education-first care continuum while preserving continuity for existing partners. Fort Worth, TX, May 04, 2026 (GLOBE NEWSWIRE) -- May 4, 2026 [...]
Flyte Increases Capacity and Launches Hiring Initiative as Spirit Airlines Shutdown Disrupts U.S. Air Travel
04/05/2026
Premium Short-Haul Operator Continues Planned Vision Jet Fleet Expansion and Opens Hiring Pipeline for Impacted Pilots and Aviation Professionals FORT MILL, SC, May 04, 2026 (GLOBE NEWSWIRE) -- — Flyte, the regional air [...]
ApolloMD Surpasses $1.5 Billion in Patient Debt Relief Through Ongoing Partnership with Cascade365, Coordinated by Undue Medical Debt
04/05/2026
ATLANTA, May 04, 2026 (GLOBE NEWSWIRE) -- ApolloMD has helped eliminate more than $1.5 billion in patient medical debt since 2018, marking a significant milestone in its ongoing partnership with Cascade365 and its [...]
MMI’s Symani Surgical System Treats First Alzheimer’s Patient in Groundbreaking REMIND Study
04/05/2026
FDA-IDE approved study enrolls first patient for robotic-assisted surgical intervention for neurodegenerative disease JACKSONVILLE, Fla., May 04, 2026 (GLOBE NEWSWIRE) -- MMI (Medical Microinstruments, Inc.), a robotics [...]
Spring Allergies Hit Lungs Hard: Doctor of Pharmacy Explains What Actually Helps
04/05/2026
Seasonal pollen doesn't just trigger sneezing. It compounds respiratory stress in ways most allergy sufferers don't expect. Austin, Texas, May 04, 2026 (GLOBE NEWSWIRE) -- Spring Allergies Hit Lungs Hard — Pharmacist [...]
Research on new class of treatments for ovarian cancer receives $725,000 in funding from Ovarian Cancer Canada to become “clinical trial-ready”
04/05/2026
HALIFAX, Nova Scotia, May 04, 2026 (GLOBE NEWSWIRE) -- To mark World Ovarian Cancer Day, Ovarian Cancer Canada is announcing a $725,000 investment to fuel critical ovarian cancer research. Led by globally respected [...]
Xpress Wellness Acquires Wichita’s Mental Health Clinic Midwest Counseling Services
04/05/2026
Acquisition furthers Xpress Wellness’ future growth in behavioral health in Kansas and Adjacent State Key facts of this press release: Xpress Wellness acquired Wichita’s Midwest Counseling Services on April 1, 2026 [...]
CDC HoST-TT Certification for Siemens Healthineers Total Testosterone Test Expands Patient Access to Gold Standard Equivalent Results
04/05/2026
Tarrytown, NY, USA, May 04, 2026 (GLOBE NEWSWIRE) -- The Atellica TSTII Testosterone assay is the only immunoassay with CDC HoST-TT Certification Certification reaffirms assay results are aligned with specialized mass [...]
Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026
04/05/2026
REDWOOD CITY, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc . (Nasdaq: CHRS), today announced that its first quarter 2026 financial results will be released after market close on Monday, May 11, 2026. [...]
Zelluna ASA: Invitation to First Quarter 2026 results webcast Presentation
04/05/2026
Oslo, Norway, 4 May 2026 – Zelluna (OSE: ZLNA), a company pioneering allogeneic “off-the-shelf” T-cell receptor-based natural killer (TCR-NK) therapies for the treatment of cancer, invites to a webcast presentation of [...]
Adjustment of accounting estimates contributes to an upgrade of revenue and operating profit guidance
04/05/2026
ANNOUNCEMENT NO. 307 4 May 2026 Adjustment of accounting estimates contributes to an upgrade of revenue and operating profit guidance To ensure continued compliance with the applicable accounting framework (IFRS), [...]
Alpha Tau Announces 100% Local Disease Control Rate and Favorable Safety Profile Observed in Alpha DaRT® Pancreatic Cancer Trials Presented at DDW 2026
04/05/2026
- 100% local disease control rate achieved in evaluable patients in pooled analysis of two first-in-human trials of Alpha DaRT ® in pancreatic adenocarcinoma - - Favorable safety profile observed, with only 8 device- [...]

Pages